Recovery of the ciliated epithelium following acute bronchiolitis in infancy

J Y W Wong1, A Rutman, C O'Callaghan

  • 1Department of Child Health, University of Leicester, School of Medicine, Robert Kilpatrick Clinical Sciences Building, Leicester Royal Infirmary, P O Box 65, Leicester LE2 7LX, UK.

Thorax
|July 5, 2005
PubMed

Insights

Infant respiratory cilia and epithelium take 13-17 weeks to recover after viral bronchiolitis. Inhaled steroids did not speed up this recovery process in the study.

Area of Science:

  • Pediatric Respiratory Medicine
  • Cell Biology
  • Clinical Trials

Background:

  • Viral bronchiolitis significantly impacts infant respiratory health.
  • Longitudinal changes in ciliated respiratory epithelium post-bronchiolitis are poorly understood.

Purpose of the Study:

  • To determine the recovery time of ciliated respiratory epithelium following infant viral bronchiolitis.
  • To investigate the efficacy of inhaled steroids in accelerating epithelial recovery.

Main Methods:

  • A clinical trial involving 31 infants treated with inhaled fluticasone (FP) or placebo for 12 weeks.
  • Nasal biopsy specimens analyzed for ciliary beat frequency (CBF) and ultrastructure via transmission electron microscopy.
  • Comparison with 19 healthy children as controls, with measurements taken at baseline and 3, 6, 12, and 24 weeks.

Main Results:

  • Ciliary beat frequency (CBF) in bronchiolitis infants gradually normalized over 24 weeks.
  • Epithelial ultrastructure abnormalities persisted for an average of 13.1 to 16.7 weeks.
  • Inhaled fluticasone showed no significant impact on CBF or epithelial recovery compared to placebo.

Conclusions:

  • Infant ciliated epithelium requires an extended period (13-17 weeks) to normalize after viral bronchiolitis.
  • Current inhaled steroid treatment protocols do not appear to expedite the natural healing process of the respiratory epithelium.
Abstract

Related Concept Videos

Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Breathing01:05

Breathing

The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...